文献速递类风湿关节炎

四分之一早期类风湿关节炎患者症状起病时间与医生报告不一致

A quarter of patients time their early rheumatoid arthritis onset differently than physicians.
PubMed 文献 · RMD Open · 2019-11-14

这项大型多中心研究比较了早期类风湿关节炎患者自报症状起病时间与风湿科医生记录的持续滑膜炎起病时间。在2683例患者中,18%患者报告起病比医生早30天以上,9%晚30天以上;报告症状持续时间更长的患者12个月时SDAI缓解率更低。

要点

  • 72%患者自报与医生记录的起病时间相差小于30天,但超过四分之一存在≥30天差异。
  • 患者报告起病早于医生者基线DAS28、肿胀关节数和血沉更低。
  • 患者报告症状持续时间更长与12个月SDAI缓解率更低相关。

核心结论

  • 超过四分之一的早期RA患者自报症状起病时间与风湿科医生记录相差超过1个月。
  • 患者报告症状持续时间比医生记录更长者,12个月时SDAI缓解率更低且医生总体评估更高。

研究设计与样本

  • 加拿大早期关节炎队列(Canadian Early ArThritis CoHort)大型多中心研究,纳入早期/疑似RA且持续滑膜炎<1年的2683例患者。
  • 患者问卷报告症状起病日期,风湿科医生记录持续滑膜炎起病日期,比较两者相差<30天与≥30天组。

主要发现

  • 2683例患者中,患者报告症状持续时间中位数178天(IQR 163),医生报告166天(IQR 138)。
  • 1940例(72%)患者自报与医生起病时间相差<30天,497例(18%)自报起病比医生早≥30天,246例(9%)晚≥30天。
  • 自报起病早于医生者基线DAS28、肿胀关节计数和血沉更低(p<0.05)。
  • 自报起病晚于医生者更常见类风湿因子阳性(p<0.001)且抗CCP抗体滴度更高(p<0.009)。
  • 回归分析显示低收入、吸烟、纤维肌痛、骨关节炎和基线使用非甲氨蝶呤非生物DMARD是患者报告症状更长的预测因素。

关键数值与推荐

  • 12个月时,自报症状持续时间比医生记录更长的患者SDAI缓解率更低、医生总体评估更高。

临床怎么用

  • 风湿免疫科医生在早期RA评估中应关注患者自报症状起病时间与医生记录的差异,尤其对合并纤维肌痛、骨关节炎、吸烟或低收入者。
  • 患者报告症状持续时间更长可能提示合并肌肉骨骼疾病,并可能预示1年缓解率更低。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Early rheumatoid arthritis (RA) treatment requires timely recognition. This large, multicentre study compared patient-reported vs physician-reported onset of early RA. METHODS: Patients from the Canadian Early ArThritis CoHort with early/suspected RA (persistent synovitis <1 year) completed questionnaires asking about the date of symptom onset; and rheumatologists date of onset for persistent synovitis. Groups with similar reported timing (patient and physician) versus differing timing of 30 days or more were compared. RESULTS: In 2683 patients, the median patient symptom duration (IQR) was 178 days (163) and physician-reported duration was 166 (138). 1940 (72%) patients had similar patient-reported and physician-reported onset (<30 days), whereas 497 (18%) reported onset 30 or more days preceding physicians, and 246 (9%) 30 or more days after physicians. Patients reporting onset preceding physicians had lower baseline Disease Activity Score based on 28 joint count, swollen joint counts and erythrocyte sedimentation rate (p<0.05). Patients reporting onset after physicians were more likely to be rheumatoid factor positive (p<0.001) and had higher anticitrullinated protein antibody titres (p<0.009). Regression showed low income, smoking, fibromyalgia, osteoarthritis and baseline non-methotrexate non-biological disease-modifying antirheumatic drug use were predictors for longer patient-reported symptoms. At 12 months, patients reporting longer symptom duration than physicians had lower rates of Simplified Disease Activity Index remission and higher physician global assessments. CONCLUSION: Over one-fourth of patients reported differences of >1 month in symptom onset from their rheumatologist. Patients with longer symptom durations had less improvement at 1 year, which may be reflective of comorbid musculoskeletal conditions.

来源:RMD Open,查看原文。版权归原作者所有。

引用

  1. Ellingwood L, Kudaeva F, Schieir O, et al. A quarter of patients time their early rheumatoid arthritis onset differently than physicians. RMD Open. 2019. PMID: 31803498. doi:10.1136/rmdopen-2019-000931

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。